Cancer Screening, Diagnostic and Genetics Services

Easy to use at-home bowel cancer screening test for men and women aged 45+

Fast track breast cancer tests, mammograms and other diagnostic investigations for men and women aged 18+

Fast-track skin cancer screening clinical service providing skin cancer tests and mole checks.

Easy to use at-home prostate cancer screening PSA test for men aged 40+

Easy to use at-home cervical cancer HPV screening test for women aged 25+

Easy to use at-home lung cancer screening test for men and women aged 50+

Rapid access appointments for screening mammograms

Easy to use at-home DNA saliva test to determine your personal risk of developing breast cancer for women aged 30+

Genetic testing for cancer – for people with a strong family history of cancer or those recently diagnosed with breast, ovarian, bowel or prostate cancer.

If genetic testing has already been carried out in your family and if a gene variant has been identified, you can be tested to see whether or not you have inherited the familial gene variant.

ProstateGene is a genetic test for people diagnosed with or at risk of prostate cancer which examines the DNA code of ten genes known to cause an increased risk of prostate cancer. It is performed on a blood sample.

OvarianGene is a genetic test for women diagnosed with or at risk of ovarian cancer which examines the DNA code of nine genes known to cause an increased risk of ovarian cancer. It is performed on a blood sample.

BowelGene is a genetic test for individuals with bowel cancer, or a strong family history of bowel cancer. It examines the DNA code of eleven genes known to be associated with an increased risk of developing bowel cancer. It is performed on a blood sample.

Jewish individuals with a personal or family history of breast or ovarian cancer may want to consider BRCA1 and BRCA2 genetic testing to understand their risk of hereditary cancer and help decide what risk reducing measures to consider.

BRCA 1 & BRCA2 Plus is a genetic test for individuals diagnosed with or at risk of breast cancer. It examines, in detail, the DNA code for nine genes which are known to cause an increased risk of breast cancer and it is performed on a blood sample.